The Middle East and Africa Ventricular Assist Device was valued at USD xx million in 2018, and is projected to reach USD xx million by 2025, growing at a CAGR of 11.2% during 2018-2025.
The key factors boosting growth of the market are high prevalence of heart failures, rise in transition to minimally invasive surgical procedure from conventional surgeries, development of innovative approaches to treat various type of cardiac diseases. In addition, increasing number of patients waiting for heart transplantation and introduction of new technological advanced products like Duraheart, Heartmate etc. will further aid to market growth.
Based on Application type, Bridge-to-transplant (BTT) Therapy is predicted to lead the market during 2018-2025
Bridge-to-transplant (BTT) Therapy segment is expected to hold maximum share in the market during the forecast period due to shortage of heart donors and growing incidence of heart failures in the middle east and Africa region. However, the highest growth rate is predicted to be exhibited by Bridge-to-recovery (BTR) Therapy segment during the forecast period.
Based on design type, Implantable design segment is anticipated to lead the market during 2018-2025
Implantable design segment is expected to hold maximum share in the market during the forecast period due to awareness regarding the product in the field of interventional cardiology along with cost effectiveness. Transcutaneous design type is anticipated to have the highest growth rate as it offers various advantages over the existing design type like lowering of blood pressure, less bleeding etc.
Further advanced devices were developed also known as third-generation devices for example DuraHeart, HeartMate III which incorporated features such as smaller size, lower rotational speeds, higher efficiency, and further enhanced anatomic design. Thus, with the development of more effective VAD, the market is expected to witness growth in future.
The companies are carrying out cardiac awareness campaigns and product launches for keeping their leadership in Middle East Africa Ventricular Assist Device market.
Various notable players operating in Middle East and Africa Ventricular Assist Device include Berlin Heart GmbH, Cardiac Assist, Inc. (LivaNova), HeartWare International, Inc., Jarvik Heart, Inc., Reliant Heart, Inc., Abbott, Sun Medical Technology Research Corp., Syncardia System, Inc., Thoratec Corporation and Abiomed among others.
The Middle East and Africa Ventricular Assist Device Market has been segmented on the basis of Application, Type and Design Segmentation. Based on Application type, the market comprises of Bridge-to-transplant (BTT) Therapy, Destination Therapy and Bridge-to-recovery (BTR) Therapy. The Product type includes Left Ventricular, Right Ventricular and Biventricular Assist Device.
The research report “Middle-East and Africa Ventricular Assist Device Market” provides in-depth analysis of the Ventricular Assist Device market, Middle East and Africa, based on application type, product type and design type for the forecast period from 2018 to 2025. The report highlights the major market drivers propelling the growth as well as challenges faced by the market participants. The research report provides market size and forecast for Ventricular Assist Device Market. The report also analyses the competitive landscape, major players and their strategies in 2018. The competitive landscape section of the report captures and highlights the recent developments in the market.
Key questions answered in this research report:
1- At what pace is the Ventricular Assist Device market growing in the region? What will be the growth trend in future?
2- What are the key drivers and restraints in the current market? What will be the impact of drivers and restraints in the coming years?
3- What are the various application areas and how they are poised to grow?
For Additional Insights Click to Access Complete Report –https://www.gmiresearch.com/report/middle-east-and-africa-ventricular-assist-device-market-mea-vad/